Clinical Trials Directory

Trials / Completed

CompletedNCT02684630

Trima Accel® System Post Count Algorithm Study

A Multicenter Study to Evaluate Modified Postcount Algorithm Software on the Trima Accel® System in Volunteer Blood Donors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
131 (actual)
Sponsor
Terumo BCT · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to optimize collected platelet yields in single and double platelet collections, while maintaining donor postplatelet count of \>100,000/µL.

Detailed description

This is a prospective, open-label, non-randomized study to evaluate Trima Accel System modified postcount algorithm software. Platelets will be collected according to the Trima Accel System Operator's Manual. Collection procedures will include those in which: 1. a single platelet product is collected 2. a double platelet product is collected, with or without other components. Study participation will be up to 8 days. The apheresis procedure can last from 25 to 150 minutes, dependent upon the product(s) to be collected, machine configuration, donor parameters, the quality of the vascular access, and the tolerance of the donor to the citrate anticoagulant. Donors will have one apheresis procedure and follow-up with any serious adverse events for 7 days.

Conditions

Interventions

TypeNameDescription
DEVICETrima Accel SystemPlatelet Apheresis Procedure

Timeline

Start date
2016-01-28
Primary completion
2016-05-28
Completion
2016-05-28
First posted
2016-02-18
Last updated
2017-07-12
Results posted
2017-06-08

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02684630. Inclusion in this directory is not an endorsement.